Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05066139

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Monocentric Randomized Study Evaluating the Impact of an Early Multidisciplinary Program in Elderly Subjects Starting a Chemotherapy for Digestive Cancer: Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Centre Paul Strauss · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.

Detailed description

At the ICANS an EPODIG-G program, consisting in a coordination of supportive care that are existing in the Institute, is proposed to elderly patients with digestive cancer. The purpose of this study is to evaluate the impact of this early multidisciplinary geriatric program (EPODIG-G), when it is initiated before therapeutic treatment.

Conditions

Interventions

TypeNameDescription
OTHEREPODIG-G program (coordination of supportive care)EPODIG-G program includes: a nutritional evaluation (laboratory tests: albumin, pre-albumin, C reactive protein and vitamin D dosage, nutritional status, Handgrip test, Simple Evaluation of Food Intake (SEFI), spontaneous food intake evaluation) ; a medication reconciliation ; physical therapy (Six Minute Walk Test)

Timeline

Start date
2021-09-17
Primary completion
2030-10-17
Completion
2030-10-17
First posted
2021-10-04
Last updated
2026-01-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05066139. Inclusion in this directory is not an endorsement.

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) (NCT05066139) · Clinical Trials Directory